NCT07231484 Effects of Grape Consumption on the Immune-Gut Axis in Obesity
| NCT ID | NCT07231484 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Missouri-Columbia |
| Condition | Obesity &Amp; Overweight |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-12-19 |
| Primary Completion | 2027-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-12-19 with a primary completion date of 2027-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.
Eligibility Criteria
Inclusion Criteria: * Age: 30-45 years * Obesity with BMI of 30-45 kg/m2 * Willingness to consume study foods * Consistent diet and activity patterns for 4 weeks * Weight stable (\<5kg change over last 3 months) * Non-smoker \> 1 year or more * Not currently consuming an extremely healthy diet Exclusion Criteria: * Study food allergies * Regular consumption of grapes or grape-derived products * Gastrointestinal disease and/or bariatric surgery * Uncontrolled hypertension and blood pressure \>180/110 * Diabetes * Clinical Depression * Illicit drug use * History of alcohol or drug abuse * Recent use of medications that affect immune function (e.g., corticosteroids) * Recent consumption of antibiotics, prebiotics, probiotics, symbiotics, or dietary supplements containing fiber or phytochemicals * Pregnant or lactating individuals * HIV positivity * Recent start of medications that affect metabolism or appetite * Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07231484 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 45 Years, studying Obesity &Amp; Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07231484 currently recruiting?
Yes, NCT07231484 is actively recruiting participants. Contact the research team at jdhillon@health.missouri.edu for enrollment information.
Where is the NCT07231484 trial being conducted?
This trial is being conducted at Columbia, United States.
Who is sponsoring the NCT07231484 clinical trial?
NCT07231484 is sponsored by University of Missouri-Columbia. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.